Automated image replacement using deformation and illumination estimation
    52.
    发明授权
    Automated image replacement using deformation and illumination estimation 有权
    使用变形和照明估计自动图像替换

    公开(公告)号:US08842118B1

    公开(公告)日:2014-09-23

    申请号:US11866401

    申请日:2007-10-02

    IPC分类号: G06T15/50 G06T15/60

    CPC分类号: G06T15/50 G06T7/30 G06T15/205

    摘要: A method which makes it possible to replace a reference pattern (aka texture) on a video of clothing is described. For example, a video of a T-shirt with the text “UCLA” could be edited to say “UC Berkeley” with minimal user intervention. The method is novel because it separates the problem into two parts: erasing the old texture (while properly accounting for lighting) and adding the new texture (properly deformed to appear on the shirt. This decomposition creates realistic images with simple tracking models of the cloth. It is believed that this method may be used for targeted audience sales techniques, with static or dynamic replacement images replacing images on warping or otherwise deforming surfaces, in addition to other perspective deformations. Potentially, real-time image replacements using the techniques taught here could be used for live activities or real-time video feeds.

    摘要翻译: 描述了可以在服装视频上替换参考图案(又称纹理)的方法。 例如,具有文本“UCLA”的T恤的视频可以用最少的用户干预来编辑来说“UC Berkeley”。 该方法是新颖的,因为它将问题分为两部分:擦除旧纹理(同时适当地计算照明),并添加新纹理(正确变形出现在衬衫上),这种分解用布的简单跟踪模型创建逼真的图像 相信这种方法可以用于目标观众销售技术,除了其他透视变形之外,还可以使用静态或动态替换图像替换曲面上的图像或其他变形曲面。潜在地,使用本教学中的技术进行实时图像替换 可用于实时活动或实时视频馈送。

    5-Amino-Oxazepine and 5-Amino-Thiazepane Compounds as Beta Secretase Antagonists and Methods of Use
    53.
    发明申请
    5-Amino-Oxazepine and 5-Amino-Thiazepane Compounds as Beta Secretase Antagonists and Methods of Use 有权
    5-氨基 - 氧氮杂和5-氨基 - 噻吖烷化合物作为β-分泌酶拮抗剂和使用方法

    公开(公告)号:US20140031340A1

    公开(公告)日:2014-01-30

    申请号:US13982222

    申请日:2012-02-06

    IPC分类号: C07D498/20 C07D498/10

    摘要: The present invention provides a new class of compounds useful for the modulation of beta-secretase enzyme (BACE) activity. The compounds have a general Formula (I); wherein variables A1, A3, A4, A5, A6, A8, R2, R7, X and Y of Formula (I) are defined herein. The invention also provides pharmaceutical compositions comprising the compounds, and corresponding uses of the compounds and compositions for treatment of disorders and/or conditions related to A-beta plaque formation and deposition, resulting from the biological activity of BACE. Such BACE mediated disorders include, for example, Alzheimer's Disease, cognitive deficits, cognitive impairments, schizophrenia and other central nervous system conditions. The invention further provides compounds of Formulas (II) and sub-formula embodiments of Formula (I) and (II), intermediates and processes and methods useful for the preparation of compounds of Formulas (I)-(II).

    摘要翻译: 本发明提供了一类可用于调节β-分泌酶(BACE)活性的化合物。 该化合物具有通式(I); 其中式(I)的变量A1,A3,A4,A5,A6,A8,R2,R7,X和Y在本文中定义。 本发明还提供包含该化合物的药物组合物,以及用于治疗由BACE的生物学活性产生的A-β斑块形成和沉积相关的病症和/或病症的化合物和组合物的相应用途。 这种BACE介导的疾病包括例如阿尔茨海默病,认知缺陷,认知障碍,精神分裂症和其他中枢神经系统疾病。 本发明进一步提供式(I)和(II)的式(II)和亚式实施方案的化合物,可用于制备式(I) - (II)化合物的中间体和方法和方法。

    Aurora kinase modulators and method of use
    55.
    发明授权
    Aurora kinase modulators and method of use 失效
    极光激酶调节剂和使用方法

    公开(公告)号:US08404694B2

    公开(公告)日:2013-03-26

    申请号:US12933400

    申请日:2009-03-19

    CPC分类号: C07D487/04

    摘要: The present invention relates to chemical compounds having a general formula I wherein A1-5 and 7-8, D′, L1, L2, R1, R3, R6-8, n and o are defined herein, and synthetic intermediates, which are capable of modulating the activity of Aurora kinase proteins and, thereby, influencing various disease states and conditions related to the activities of Aurora kinases. For example, the compounds are capable of influencing the process of cell cycle and cell proliferation to treat cancer and cancer-related diseases. The invention also includes pharmaceutical compositions, including the compounds, and methods of treating disease states related to the activity of Aurora kinase.

    摘要翻译: 本发明涉及具有通式I的化合物,其中A1-5和7-8,D',L1,L2,R1,R3,R6-8,n和o如本文所定义,和合成中间体,其能够 调节极光激酶蛋白的活性,从而影响与极光激酶活性相关的各种疾病状态和状况。 例如,化合物能够影响细胞周期和细胞增殖的过程,以治疗癌症和与癌症有关的疾病。 本发明还包括药物组合物,包括该化合物,以及治疗与Aurora激酶活性有关的疾病状态的方法。

    Security system with lock interface member with multiple apertures
    56.
    发明授权
    Security system with lock interface member with multiple apertures 有权
    具有多个孔的锁定接口构件的安全系统

    公开(公告)号:US08230707B2

    公开(公告)日:2012-07-31

    申请号:US12599844

    申请日:2008-05-21

    申请人: John Hung Ryan White

    发明人: John Hung Ryan White

    IPC分类号: E05B69/00

    摘要: A system is disclosed. It includes a portable electronic device comprising a lock interface member having a first aperture configured to engage with a first security apparatus and a second aperture configured to engage with a second security apparatus. At least one of the first security apparatus and the second security apparatus is engaged with the lock interface member.

    摘要翻译: 公开了一种系统。 它包括便携式电子设备,其包括锁定接口构件,该锁定接口构件具有被配置为与第一安全装置接合的第一孔和被配置为与第二安全装置接合的第二孔。 第一安全装置和第二安全装置中的至少一个与锁接口构件接合。

    SECURITY APPARATUS
    59.
    发明申请
    SECURITY APPARATUS 审中-公开
    安全装置

    公开(公告)号:US20100300158A1

    公开(公告)日:2010-12-02

    申请号:US12446568

    申请日:2007-10-22

    IPC分类号: E05B73/00

    摘要: A security apparatus is disclosed. The security apparatus is used with a lock interface member attached to a housing of a portable electronic device. The security apparatus may include a head comprising a plurality of engagement elements adapted to engage the lock interface member via the engagement regions, where the engagement elements are capable of extending radially outward to engage the engagement regions of the interface member.

    摘要翻译: 公开了一种安全装置。 安全装置与附接到便携式电子装置的壳体的锁定接口构件一起使用。 安全装置可以包括头部,头部包括适于经由接合区域接合锁定接口构件的多个接合元件,其中接合元件能够径向向外延伸以接合接口构件的接合区域。